These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34162444)

  • 1. Evaluation of cannabidiol's inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids.
    Ma H; Li H; Liu C; Seeram NP
    J Cannabis Res; 2021 Jun; 3(1):20. PubMed ID: 34162444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Network Pharmacology Approach to Identify Potential Molecular Targets for Cannabidiol's Anti-Inflammatory Activity.
    Ma H; Xu F; Liu C; Seeram NP
    Cannabis Cannabinoid Res; 2021 Aug; 6(4):288-299. PubMed ID: 33998855
    [No Abstract]   [Full Text] [Related]  

  • 3. α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from
    Suttithumsatid W; Shah MA; Bibi S; Panichayupakaranant P
    Curr Res Food Sci; 2022; 5():1091-1097. PubMed ID: 35856057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational in silico design of novel α-glucosidase inhibitory peptides and in vitro evaluation of promising candidates.
    Ibrahim MA; Bester MJ; Neitz AW; Gaspar ARM
    Biomed Pharmacother; 2018 Nov; 107():234-242. PubMed ID: 30096627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries.
    Aychman MM; Goldman DL; Kaplan JS
    Front Neurol; 2023; 14():1087011. PubMed ID: 36816569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.
    Pelz MC; Schoolcraft KD; Larson C; Spring MG; López HH
    Epilepsy Behav; 2017 Aug; 73():111-118. PubMed ID: 28624721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of molecular interactions between cannabidiol and human plasma proteins (serum albumin and γ-globulin) by surface plasmon resonance, microcalorimetry, and molecular docking.
    Liu C; Cai A; Li H; Deng N; Cho BP; Seeram NP; Ma H
    J Pharm Biomed Anal; 2022 May; 214():114750. PubMed ID: 35398615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol's Upregulation of
    Leishman E; Manchanda M; Thelen R; Miller S; Mackie K; Bradshaw HB
    Cannabis Cannabinoid Res; 2018; 3(1):228-241. PubMed ID: 30515459
    [No Abstract]   [Full Text] [Related]  

  • 10. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.
    Olivas-Aguirre M; Torres-López L; Villatoro-Gómez K; Perez-Tapia SM; Pottosin I; Dobrovinskaya O
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of cannabidiol's potential targets in limbic seizures.
    Olafuyi O; Kapusta K; Reed A; Kolodziejczyk W; Saloni J; Hill GA
    J Biomol Struct Dyn; 2023; 41(16):7744-7756. PubMed ID: 36129109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
    Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
    Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
    Chye Y; Christensen E; Solowij N; Yücel M
    Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.
    Seong SH; Roy A; Jung HA; Jung HJ; Choi JS
    J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin inhibits α-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats.
    Priscilla DH; Roy D; Suresh A; Kumar V; Thirumurugan K
    Chem Biol Interact; 2014 Mar; 210():77-85. PubMed ID: 24412302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic effects of Brucea javanica seeds in type 2 diabetic rats.
    Ablat A; Halabi MF; Mohamad J; Hasnan MH; Hazni H; Teh SH; Shilpi JA; Mohamed Z; Awang K
    BMC Complement Altern Med; 2017 Feb; 17(1):94. PubMed ID: 28166749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Anthocyanidins and Anthocyanins for Targeting α-Glucosidase in Diabetes Mellitus.
    Promyos N; Temviriyanukul P; Suttisansanee U
    Prev Nutr Food Sci; 2020 Sep; 25(3):263-271. PubMed ID: 33083375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.